Lv4
520 积分 2025-07-16 加入
Treatment of Short Stature in Aggrecan-deficient Patients With Recombinant Human Growth Hormone: 1-Year Response
10天前
已完结
Clinical Characteristics of Pathogenic ACAN Variants and 3-Year Response to Growth Hormone Treatment: Real-World Data
10天前
已完结
Phenotypic Characterization and rhGH Therapeutic Response in ACAN Children with Short Stature: A Real-World Study
10天前
已关闭
Phenotypic Characterization and rhGH Therapeutic Response in ACAN Children with Short Stature: A Real-World Study
11天前
已关闭
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS)
1个月前
已完结
Trial-level factors affecting accrual rate of systemic sclerosis randomized clinical trials
1个月前
已完结
Suppression of T Cell Activation and Collagen Accumulation by an Anti-IFNAR1 mAb, Anifrolumab, in Adult Patients with Systemic Sclerosis
1个月前
已完结
Successful Treatment of Refractory Severe Localized Scleroderma With Anifrolumab
1个月前
已完结
Interferons in Sjogren's disease: current status and future prospects
2个月前
已完结
Effects of an Oral Growth Hormone Secretagogue in Older Adults
2个月前
已完结
皖公网安备34019202002308
